83 results
8-K
EX-99.1
RNLX
Renalytix Plc
28 May 24
Departure of Directors or Certain Officers
7:15am
, with a combined 200+ years of healthcare and in-vitro diagnostic experience, has designed its KidneyIntelX laboratory developed test to enable risk
424B5
RNLX
Renalytix Plc
15 May 24
Prospectus supplement for primary offering
10:09am
with healthcare systems to incorporate KidneyIntelX into their treatment regime and integrate their EHR systems with our technology, our revenue
8-K
EX-99.1
hc0wdt
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
424B3
gox98p 5c2xihv
7 May 24
Prospectus supplement
6:29pm
8-K
EX-99.1
irk 9pp3y6rjlbmv
26 Apr 24
Allotment and issue of the Second Tranche Placing Shares
7:43am
8-K
cegae8
23 Apr 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
qnodwgii
23 Apr 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.2
vo9ka5
23 Apr 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
t8fc6nb
10 Apr 24
Unregistered Sales of Equity Securities
4:01pm
8-K
EX-5.1
tqzg 4enak
9 Apr 24
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.1
v5en5
9 Apr 24
Entry into a Material Definitive Agreement
4:51pm
424B5
kaizzq 2lgcd60o018
9 Apr 24
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
lbuas4ckwe
8 Apr 24
Regulation FD Disclosure
7:44am
8-K
EX-99.1
08t7nhlrxzwr0g43
14 Mar 24
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
7:15am
8-K
EX-99.1
jh6eyh
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.2
c3sa62sb38tmb0o
13 Mar 24
Entry into a Material Definitive Agreement
7:00am